TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05619588: Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only

Sponsor: Exactech · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 370 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$11,040,000

Rescue Site Savings

+$7,279,500

Unlock Full NCT05619588 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05619588 Rescue Dossier →